The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diagnostic Biomarkers-Global Market Insights and Sales Trends 2025
Synopsis
The global Diagnostic Biomarkers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diagnostic Biomarkers in various end use industries. The expanding demands from the Hospitals, Cancer Research Institutes and Diagnostic Labs,, are propelling Diagnostic Biomarkers market. Safety Biomarkers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Efficacy Biomarkers segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diagnostic Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diagnostic Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diagnostic Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diagnostic Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diagnostic Biomarkers covered in this report include Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas and Cisbio Bioassays, etc.
The global Diagnostic Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Global Diagnostic Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diagnostic Biomarkers market, Segment by Type:
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Global Diagnostic Biomarkers market, by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diagnostic Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Diagnostic Biomarkers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diagnostic Biomarkers in various end use industries. The expanding demands from the Hospitals, Cancer Research Institutes and Diagnostic Labs,, are propelling Diagnostic Biomarkers market. Safety Biomarkers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Efficacy Biomarkers segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diagnostic Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diagnostic Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diagnostic Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diagnostic Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diagnostic Biomarkers covered in this report include Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas and Cisbio Bioassays, etc.
The global Diagnostic Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Global Diagnostic Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diagnostic Biomarkers market, Segment by Type:
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Global Diagnostic Biomarkers market, by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diagnostic Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diagnostic Biomarkers
1.1 Diagnostic Biomarkers Market Overview
1.1.1 Diagnostic Biomarkers Product Scope
1.1.2 Diagnostic Biomarkers Market Status and Outlook
1.2 Global Diagnostic Biomarkers Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diagnostic Biomarkers Market Size by Region (2018-2029)
1.4 Global Diagnostic Biomarkers Historic Market Size by Region (2018-2023)
1.5 Global Diagnostic Biomarkers Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diagnostic Biomarkers Market Size (2018-2029)
1.6.1 North America Diagnostic Biomarkers Market Size (2018-2029)
1.6.2 Europe Diagnostic Biomarkers Market Size (2018-2029)
1.6.3 Asia-Pacific Diagnostic Biomarkers Market Size (2018-2029)
1.6.4 Latin America Diagnostic Biomarkers Market Size (2018-2029)
1.6.5 Middle East & Africa Diagnostic Biomarkers Market Size (2018-2029)
2 Diagnostic Biomarkers Market by Type
2.1 Introduction
2.1.1 Safety Biomarkers
2.1.2 Efficacy Biomarkers
2.1.3 Validation Biomarkers
2.2 Global Diagnostic Biomarkers Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diagnostic Biomarkers Historic Market Size by Type (2018-2023)
2.2.2 Global Diagnostic Biomarkers Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diagnostic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diagnostic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diagnostic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diagnostic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diagnostic Biomarkers Revenue Breakdown by Type (2018-2029)
3 Diagnostic Biomarkers Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Cancer Research Institutes
3.1.3 Diagnostic Labs
3.2 Global Diagnostic Biomarkers Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diagnostic Biomarkers Historic Market Size by Application (2018-2023)
3.2.2 Global Diagnostic Biomarkers Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diagnostic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diagnostic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diagnostic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diagnostic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diagnostic Biomarkers Revenue Breakdown by Application (2018-2029)
4 Diagnostic Biomarkers Competition Analysis by Players
4.1 Global Diagnostic Biomarkers Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2022)
4.3 Date of Key Players Enter into Diagnostic Biomarkers Market
4.4 Global Top Players Diagnostic Biomarkers Headquarters and Area Served
4.5 Key Players Diagnostic Biomarkers Product Solution and Service
4.6 Competitive Status
4.6.1 Diagnostic Biomarkers Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Qiagen N.V.
5.1.1 Qiagen N.V. Profile
5.1.2 Qiagen N.V. Main Business
5.1.3 Qiagen N.V. Diagnostic Biomarkers Products, Services and Solutions
5.1.4 Qiagen N.V. Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.1.5 Qiagen N.V. Recent Developments
5.2 Perkinelmer, Inc.
5.2.1 Perkinelmer, Inc. Profile
5.2.2 Perkinelmer, Inc. Main Business
5.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Products, Services and Solutions
5.2.4 Perkinelmer, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.2.5 Perkinelmer, Inc. Recent Developments
5.3 Merck Millipore
5.3.1 Merck Millipore Profile
5.3.2 Merck Millipore Main Business
5.3.3 Merck Millipore Diagnostic Biomarkers Products, Services and Solutions
5.3.4 Merck Millipore Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Laboratories, Inc. Recent Developments
5.4 Bio-Rad Laboratories, Inc.
5.4.1 Bio-Rad Laboratories, Inc. Profile
5.4.2 Bio-Rad Laboratories, Inc. Main Business
5.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Products, Services and Solutions
5.4.4 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Laboratories, Inc. Recent Developments
5.5 Enzo Biochem, Inc.
5.5.1 Enzo Biochem, Inc. Profile
5.5.2 Enzo Biochem, Inc. Main Business
5.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Products, Services and Solutions
5.5.4 Enzo Biochem, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.5.5 Enzo Biochem, Inc. Recent Developments
5.6 EKF Diagnostics Holdings, Inc.
5.6.1 EKF Diagnostics Holdings, Inc. Profile
5.6.2 EKF Diagnostics Holdings, Inc. Main Business
5.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Products, Services and Solutions
5.6.4 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.6.5 EKF Diagnostics Holdings, Inc. Recent Developments
5.7 Meso Scale Diagnostics, LLC.
5.7.1 Meso Scale Diagnostics, LLC. Profile
5.7.2 Meso Scale Diagnostics, LLC. Main Business
5.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Products, Services and Solutions
5.7.4 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.7.5 Meso Scale Diagnostics, LLC. Recent Developments
5.8 Biosims Technologies Sas
5.8.1 Biosims Technologies Sas Profile
5.8.2 Biosims Technologies Sas Main Business
5.8.3 Biosims Technologies Sas Diagnostic Biomarkers Products, Services and Solutions
5.8.4 Biosims Technologies Sas Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.8.5 Biosims Technologies Sas Recent Developments
5.9 Cisbio Bioassays
5.9.1 Cisbio Bioassays Profile
5.9.2 Cisbio Bioassays Main Business
5.9.3 Cisbio Bioassays Diagnostic Biomarkers Products, Services and Solutions
5.9.4 Cisbio Bioassays Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.9.5 Cisbio Bioassays Recent Developments
5.10 Signosis, Inc
5.10.1 Signosis, Inc Profile
5.10.2 Signosis, Inc Main Business
5.10.3 Signosis, Inc Diagnostic Biomarkers Products, Services and Solutions
5.10.4 Signosis, Inc Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.10.5 Signosis, Inc Recent Developments
5.11 Banyan Biomarkers, Inc
5.11.1 Banyan Biomarkers, Inc Profile
5.11.2 Banyan Biomarkers, Inc Main Business
5.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Products, Services and Solutions
5.11.4 Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.11.5 Banyan Biomarkers, Inc Recent Developments
5.12 Biomedical Corp
5.12.1 Biomedical Corp Profile
5.12.2 Biomedical Corp Main Business
5.12.3 Biomedical Corp Diagnostic Biomarkers Products, Services and Solutions
5.12.4 Biomedical Corp Diagnostic Biomarkers Revenue (US$ Million) & (2018-2023)
5.12.5 Biomedical Corp Recent Developments
6 North America
6.1 North America Diagnostic Biomarkers Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diagnostic Biomarkers Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Biomarkers Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diagnostic Biomarkers Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Biomarkers Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diagnostic Biomarkers Market Dynamics
11.1 Diagnostic Biomarkers Industry Trends
11.2 Diagnostic Biomarkers Market Drivers
11.3 Diagnostic Biomarkers Market Challenges
11.4 Diagnostic Biomarkers Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
